Study and Monitoring of Multiple Endocrine Neoplasia Type 1

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

1600 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-04-05

Study Completion Date

2029-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Multiple Endocrine Neoplasia Type I (MEN1) is a rare autosomal dominant disorder, predisposing sufferers to the development of endocrine tumors. The three most commont endocrine disorders of MEN1 are the secretory tumours of the parathyroid, pituitary gland and pancreas, in addition to which other tumours may be observed.

The diagnosis of MEN1 is essential for 1) appropriate therapeutic management of proven endocrine disorders, 2) screening for other endocrine and non-endocrine tumours, 3) family screening of affected relatives and 4) monitoring of patients who have been diagnosed. Undiagnosed MEN1 is one of the reasons for therapeutic failure in the management of endocrine damage. Detection is therefore of major importance, and any improvement in early diagnosis can improve management.

The natural history of the disease in all its clinical forms remains poorly understood, with published studies of selected or small populations. There are still clinical forms that are difficult to link to the syndrome. These clinical forms need to be specified in order to ensure optimal management. Only a large cohort will lead to the identification of the various forms of this condition and clarify its prognosis.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study and Follow-up of Multiple Endocrine Neoplasia Type 1

NCT03348501

Multiple Endocrine Neoplasia

RECRUITING

Evaluation of Patients With Endocrine-Related Conditions

NCT00005664

Adrenal Insufficiency Pituitary Neoplasm Obesity

TERMINATED

Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors

NCT01568359

Acromegaly Nonfunctioning Pituitary Tumor

COMPLETED

Clinical Outcome of Autonomous Cortisol Secretion in Adrenal Incidentalomas

NCT04917757

Adrenal Incidentaloma

ACTIVE_NOT_RECRUITING

An Investigation of Pituitary Tumors and Related Hypothalmic Disorders

NCT00001595

Panhypopituitarism Gigantism/Acromegaly Prolactinoma +1 more

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

MEN1

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Questionnaires

Questionnaires about:

* Socio-professional situation
* Lifestyle
* Health
* NME 1
* specific breast cancer survey
* Imaging

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

SYMPTOMATIC PATIENTS

* person (adult or minor) who has not opposed participation
* if the patient is a minor, the parents must not oppose their child's participation,
* at least two of the three main types of lesions (parathyroid, pancreas, pituitary gland)
* OR a known isolated tumor, main type or not, associated with the gene mutation of the NEM1 locus on chromosome 11q13
* OR an isolated tumor, main type or not, in an individual with a confirmed family history of NEM1

ASYMPTOMATIC PATIENTS WITH A MUTATION

\- Presence of a characteristic mutation of NEM1

Eligible Sex

ALL

Accepts Healthy Volunteers

No